Bexil (BXLC) AI Stock Analysis

Bexil

(Other OTC:BXLC)

Select Model

Rating:74Outperform

Price Target:$70.00▲(11.96% Upside)

Action:reiterated

Date:08/17/26

The score is led by strong financial positioning (notably a debt-free balance sheet and improved profitability) and a low P/E that supports valuation. These positives are tempered by weaker technical momentum (negative MACD, low RSI, and price below longer-term moving averages) and fundamental durability concerns from shrinking TTM revenue and weaker cash conversion versus net income.

Positive Factors

Debt-Free Balance SheetMinimal leverage limits interest burden and refinancing risk, giving Bexil greater resilience through weaker operating periods. The substantial equity base also provides financial flexibility to preserve operations or pursue opportunities without relying heavily on external funding.

Negative Factors

Shrinking Revenue BaseA substantial top-line contraction challenges the durability of the current earnings profile and may indicate reduced business activity or fewer recurring opportunities. Sustained revenue pressure could eventually limit operating scale, investment capacity, and future profit growth.

Bexil (BXLC) vs. SPDR S&P 500 ETF (SPY)

Market Cap: $30.65M
Dividend Yield: ―
Average Volume (3M): 100
Price to Earnings (P/E): 4.8
Beta (1Y): 0.26
Revenue Growth: 29.83%
EPS Growth: 100.03%
Country: US
Employees: 5
Sector: Financial
Sector Strength: 68
Industry: Asset Management

Bexil Business Overview & Revenue Model

Company Description

Bexil Corporation, established in 1996 and headquartered in Millbrook, New York, primarily operates in the United States. The company focuses on investment management and securities trading, conducting these activities through its various subsidiary...

How the Company Makes Money

null

Bexil Financial Statement Overview

Summary

Strong overall financial footing driven by a conservatively positioned, debt-free balance sheet and a return to solid profitability versus the 2022 loss. Offsetting factors are a meaningful TTM revenue decline (~31%), volatile margins, and weaker earnings-to-free-cash-flow conversion in the latest period (FCF ~$2.68M vs net income ~$6.92M).

Income Statement

74Positive

Balance Sheet

89Very Positive

Cash Flow

70Positive

Financial statement breakdown
Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Mar 2022
Income Statement
Total Revenue	3.67M	3.13M	5.12M	5.91M	2.75M	2.84M
Gross Profit	3.67M	3.13M	5.12M	5.91M	2.75M	8.70M
EBITDA	9.14M	7.40M	3.59M	4.26M	-3.27M	5.36M
Net Income	6.92M	5.63M	3.12M	3.15M	-1.76M	6.49M
Balance Sheet
Total Assets	32.06M	30.48M	26.60M	28.94M	26.24M	28.14M
Cash, Cash Equivalents and Short-Term Investments	2.34M	3.12M	23.84M	25.55M	18.33M	23.65M
Total Debt	160.51K	0	73.47K	0	0	0
Total Liabilities	788.54K	447.76K	305.21K	1.20M	155.81K	261.00K
Stockholders Equity	31.46M	30.22M	26.47M	27.25M	26.26M	28.05M
Cash Flow
Free Cash Flow	2.68M	2.68M	443.12K	1.73M	2.29M	2.56M
Operating Cash Flow	2.68M	2.68M	443.12K	1.73M	2.29M	2.56M
Investing Cash Flow	-146.69K	-9,790	-1.29M	1.37M	-3.56M	-354.68K
Financing Cash Flow	-2.01M	-2.31M	-3.89M	-1.38M	92.30K	-2.23M

Bexil Technical Analysis

Technical Analysis SentimentPositive

Last Price62.52

Price Trends

50DMA62.46Positive

100DMA62.68Negative

200DMA63.84Negative

Market Momentum

MACD0.00Positive

RSI51.37Neutral

STOCH49.90Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BXLC, the sentiment is Positive. The current price of 62.52 is above the 20-day moving average (MA) of 62.52, above the 50-day MA of 62.46, and below the 200-day MA of 63.84, indicating a neutral trend. The MACD of 0.00 indicates Positive momentum. The RSI at 51.37 is Neutral, neither overbought nor oversold. The STOCH value of 49.90 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BXLC.

Bexil Peers Comparison

Overall Rating

UnderperformOutperform

Sector (68)

Financial Indicators

BXLC against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
BXLC	74Outperform	$31.94M	4.75	22.89%	―	29.83%	100.03%
Sector *	68Neutral	$18.00B	11.42	9.92%	3.81%	9.73%	1.22%
BCG	67Neutral	$18.42M	6.13	26.91%	―	8.29%	―
MGLD	63Neutral	$84.14M	-19.27	-19.94%	―	-4.76%	27.34%
RAND	56Neutral	$28.21M	-237.50	-0.28%	18.11%	-71.45%	97.98%

* Financial Sector Average

Performance Comparison

BXLC and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
BXLC	Bexil Corporation	62.52	-2.48	-3.81%
RAND	Rand Capital	9.50	-2.50	-20.85%
MGLD	Marygold Companies, Inc.	1.97	0.90	84.11%
BCG	Binah Capital Group, Inc.	1.08	-0.55	-33.74%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026

Bexil AI Stock Analysis